Condition
Pneumococcal Immunization clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Pneumococcal Immunization clinical trials that are recruiting, at sites in 5 countries (most in South Korea (1), Honduras (1), Puerto Rico (1)). By phase: Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 5Countries
All recruiting trials (2)
-
Comparing three production lots of a 21‑valent pneumococcal vaccine in infants
This trial will test if three different production lots of a 21‑valent pneumococcal vaccine give similar immune responses and are as safe as the licensed 20‑valent vaccine when given to infants starting at about 2 months of age.
-
Safety monitoring of Prevenar 20 in people in Korea
This project will see if the Prevenar 20 vaccine is safe for people in the Republic of Korea aged 6 weeks and older who are prescribed it.
Quick answers
How many Pneumococcal Immunization clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 5 countries. The most sites are in South Korea (1 trial), Honduras (1 trial), Puerto Rico (1 trial), Thailand (1 trial), United States (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.